Arcturus Therapeutics
Recent Finacing
Equity
Recent Raise
$9M
Arcturus Therapeutics is developing an inhaled mRNA therapy for cystic fibrosis, delivering the mRNA template to lung cells using a lipid nanoparticle.
Focus Areas
Biotechnology
Cystic Fibrosis Research
mRNA Therapies
Investors
